Get started
Author

François Liebaert

Observed names: F. Liebaert, Francois Liebaert, Liebaert, F
OpenAlex ID: A5071102770
Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trial
2017 · Siân Pugh, Raphaële Thiébaut, et al. · Oncotarget · 54
PDF
Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer
2018 · Pierre Laurent-Puig, Marie-Lise Grisoni, et al. · Clinical Cancer Research · 49
Helicobacter pylori “Test‐and‐Treat” strategy with urea breath test: A cost‐effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain—Results of the Hp‐Breath initiative
2020 · Ariel Beresniak, Peter Malfertheiner, et al. · Helicobacter · 44
High concentration of topical amitriptyline for treating chemotherapy-induced neuropathies
2019 · Julien Rossignol, Benoit Cozzi, et al. · Supportive Care in Cancer · 32
MiR 31 3p as a predictive biomarker of cetuximab efficacy effect in metastatic colorectal cancer (mCRC) patients enrolled in FIRE-3 study.
2016 · Pierre Laurent-Puig, Marie-Lise Grisoni, et al. · Journal of Clinical Oncology · 17
Evaluation of miR 31 3p as a biomarker of prognosis and panitumumab benefit in RAS-wt advanced colorectal cancer (aCRC): Analysis of patients (pts) from the PICCOLO trial.
2015 · Pierre Laurent-Puig, Sophie Paget-Bailly, et al. · Journal of Clinical Oncology · 13
Mir-31-3p as a predictive biomarker of cetuximab effects in a post hoc analysis of new EPOC phase III trial.
2014 · Pierre Laurent-Puig, John A. Bridgewater, et al. · Journal of Clinical Oncology · 3
Analysis of progression-free survival in the new EPOC study in an “all wild-type” population.
2014 · John A. Bridgewater, Sian Alexandra Pugh, et al. · Journal of Clinical Oncology · 2
Hsa-miR-31-3p expression in FFPE tumor samples as a predictor of anti-EGFR response in patients with metastatic colorectal cancer.
2013 · Gilles Manceau, Jean-Baptiste Bachet, et al. · Journal of Clinical Oncology · 2
Mir-31-3P is a Predictive Biomarker of Cetuximab Effects in a Post-Hoc Analysis in the New Epoc Study
2014 · P. Laurent-Puig, J.A. Bridgewater, et al. · Annals of Oncology · 1
Hsa-mir-31-3p effects on gene expression in colorectal cancer cell lines and patients.
2013 · Raphaële Thiébaut, Marc Vincent, et al. · Journal of Clinical Oncology · 1
Supplementary Materials from Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer
2023 · Pierre Laurent-Puig, Marie-Lise Grisoni, et al.
PDF
Data from Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer
2023 · Pierre Laurent-Puig, Marie-Lise Grisoni, et al.
Data from Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer
2023 · Pierre Laurent-Puig, Marie-Lise Grisoni, et al.
Association between c-Met expression, miR-31-3p expression and progression free survival in the New EPOC study.
2015 · Sian Alexandra Pugh, John A. Bridgewater, et al. · Journal of Clinical Oncology
Mir31-3P Expression in Patients with Advanced Lepidic Adenocarcinoma (L-ADC) Treated with EGFR Tki in Ifct 0401 and 0504 Trials
2015 · R. Thiebaut, M. Wislez, et al. · Annals of Oncology
Analysis of Progression Free Survival in the New Epoc Study in an All Ras Wild-Type Population
2014 · J.A. Bridgewater, S.A. Pugh, et al. · Annals of Oncology
HSA-MIR31-3P Expression as a Predictor of Anti-Egfr Response in Wild-Type Kras Patients with Metastatic Colorectal Cancer
2012 · P. Laurent-Puig, G. Manceau, et al. · Annals of Oncology
PDF
miRNA expression as a predictor of survival in patients with metastatic colorectal cancer treated with EGFR inhibitors.
2012 · Sandrine Imbeaud, Gilles Manceau, et al. · Journal of Clinical Oncology
Works count: 20
Citation count: 218
H-index: 6
I10-index: 6
Year
Topic
Type